Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1156039/000115603920000003/antm-2019123110kq42019.htm
June 2022
May 2022
April 2022
April 2022
March 2022
January 2022
October 2021
September 2021
August 2021
July 2021
Exhibit 99.1
PRESS RELEASE
ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS
REFLECTING SOLID PERFORMANCE
| Fourth quarter net income was $3.62 per share, including net negative adjustment items of $0.26 per share. Adjusted net income was $3.88* per share. |
| Full year net income was $18.47 per share, including net negative adjustment items of $0.97 per share. Adjusted net income was $19.44* per share. |
| Fourth quarter operating revenue grew 16.4% year-over-year to $27.1 billion. Full year operating revenue grew 12.9% year-over-year to $103.1 billion. |
| Medical enrollment ended the year at 41 million lives, with growth of 1.1 million members year-to-date, driven by the risk-based businesses. |
| Full year 2020 GAAP net income is expected to be greater than $21.44 per share. Adjusted net income is expected to be greater than $22.30* per share, an increase of 14.7% versus 2019, including approximately $2.30 from the accelerated launch of IngenioRx. |
| Quarterly dividend increased by nearly 19% to $0.95 per share. |
Indianapolis, Ind. January 29, 2020 Anthem, Inc. (NYSE: ANTM) reported fourth quarter and full year financial 2019 results that reflect double-digit top and bottom line growth and the successful launch of IngenioRx.
Anthem delivered strong results to close out 2019 featuring the successful launch of IngenioRx, as well as our largest organic risk-based growth in more than a decade, said Gail K. Boudreaux, President and CEO. We have strong momentum moving into 2020 and we will continue to deliver on our commitments to all those we serve.
* | Refer to the GAAP reconciliation tables on page 14. |
1
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1156039/000115603920000003/antm-2019123110kq42019.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Anthem, Inc..
Anthem, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:
Rating
Learn More![]()
We maintained a strong financial condition and liquidity position, with consolidated cash, cash equivalents and investments in fixed maturity and equity securities of $26,157 at December 31, 2019.
These claims-related costs may be comprised of expenses incurred for: (i) medical management, including case and prospective utilization management; (ii) health and wellness, including disease management services for such conditions as diabetes, high-risk pregnancies, congestive heart failure and asthma management and wellness initiatives like weight-loss programs and smoking cessation treatments; and (iii) clinical health policy, such as identification and use of best clinical practices to avoid harm, identifying clinical errors and safety concerns, and identifying potential adverse drug interactions.
Effective January 1, 2019, we curtailed the benefits under the Anthem Cash Balance Plan B pension plan.
This assumed long-term rate of return on assets is applied to a calculated value of plan assets, which recognizes changes in the fair value of plan assets in a systematic manner over three years, producing the expected return on plan assets that is included in the determination of pension expense.
For information regarding new accounting pronouncements that were issued or became effective during the year ended December 31, 2019 that had, or are expected to have, a material impact on our financial position, results of operations or financial statement disclosures, see the "Recently Adopted Accounting Guidance" and "Recent Accounting Guidance Not Yet Adopted" sections of Note 2, "Basis of Presentation and Significant Accounting Policies," of the Notes to Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K.
Medicaid membership represents eligible members...Read more
A Medicare Advantage or Medicare...Read more
Other significant changes in sources...Read more
Under the spot rate approach,...Read more
Our results of operations depend...Read more
A summary of our major...Read more
Benefit expense increased primarily due...Read more
We follow FASB guidance for...Read more
Our affected products are priced...Read more
Our cash receipts result primarily...Read more
However, over time, the economic...Read more
These increases were partially offset...Read more
Our benefit expense primarily includes...Read more
For the year ended December...Read more
For the year ended December...Read more
If it is determined that...Read more
There are many drivers of...Read more
Operating revenue increased primarily due...Read more
Since December 31, 2018, total...Read more
The increase in administrative fees...Read more
The increase in operating gain...Read more
Any future decline in our...Read more
The discussion of segment results...Read more
The annual HIP Fee is...Read more
Selling, general and administrative expense...Read more
These types of claims-related costs...Read more
Vision membership increased primarily due...Read more
We use various actuarial assumptions,...Read more
We work to mitigate these...Read more
As permitted by the guidance,...Read more
The increase in administrative fees...Read more
We have experienced growth in...Read more
The higher premiums were largely...Read more
Should commercial paper issuance be...Read more
The increase in operating cash...Read more
The increase in operating revenue...Read more
In our analysis for the...Read more
We record this liability and...Read more
Conversely, a decrease in the...Read more
As discussed above, these two...Read more
We have an authorized commercial...Read more
If our credit ratings are...Read more
Our net income as a...Read more
For the year ended December...Read more
In the second quarter of...Read more
We use operating gain to...Read more
At December 31, 2019, we...Read more
In May 2017, we announced...Read more
Cash disbursements result mainly from...Read more
Medicare membership increased primarily due...Read more
-55- Operating revenue increased due...Read more
The above table does not...Read more
Under this approach, only accumulated...Read more
Fully-insured products are products in...Read more
Year Ended December 31, 2019...Read more
In February 2018, we completed...Read more
A portion of benefit expense...Read more
At December 31, 2019, we...Read more
Medical Cost Trends: Our medical...Read more
In July 2019, we announced...Read more
For all other securities, cash...Read more
For example, an increase in...Read more
Certain accounting practices prescribed by...Read more
This could result in OTTI...Read more
We consider our most important...Read more
The customer's buying decision is...Read more
For securities not actively traded,...Read more
Estimates can require a significant...Read more
Medicare customers are Medicare-eligible individual...Read more
Plan assets include a diversified...Read more
We anticipate the Local Group...Read more
These tests involve the use...Read more
The increase in premium revenue...Read more
These qualitative impairment tests include...Read more
For mortgage-backed and asset-backed securities,...Read more
Administrative fees and other revenue...Read more
Medicaid membership increased primarily due...Read more
The increase in EPS resulted...Read more
The discount rate reflects the...Read more
December 31, 2019 Compared to...Read more
Pricing Trends: We strive to...Read more
We believe we have adequately...Read more
The increase in premiums was...Read more
We obtain quoted market prices...Read more
Our Level III securities primarily...Read more
This quarterly dividend is payable...Read more
We believe we have adequately...Read more
Our analysis includes procedures such...Read more
These increases in premiums were...Read more
We classify certain claims-related costs...Read more
Medicare Advantage SNPs are coordinated...Read more
These adjustments are made by...Read more
We believe we have an...Read more
The sum of goodwill and...Read more
Also, in the second quarter...Read more
Our effective tax rate decreased...Read more
This acquisition aligned with our...Read more
This acquisition aligned with our...Read more
Our consolidated goodwill at December...Read more
Under the guidance, goodwill and...Read more
Furthermore, goodwill and other intangible...Read more
Our impairment tests require us...Read more
Our regulated subsidiaries' states of...Read more
We calculate the percentage of...Read more
This information is not intended...Read more
-61- For additional information, see...Read more
Our medical membership includes seven...Read more
We also calculate operating gain...Read more
Circumstances to be considered in...Read more
Operating gain is calculated as...Read more
Operating gain is calculated as...Read more
Operating revenue for the year...Read more
While considered benefit expense or...Read more
We believe our assumption of...Read more
The net present value is...Read more
FEHB members consist of United...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Anthem, Inc. provided additional information to their SEC Filing as exhibits
Ticker: ANTM
CIK: 1156039
Form Type: 10-K Annual Report
Accession Number: 0001156039-20-000003
Submitted to the SEC: Wed Feb 19 2020 3:14:06 PM EST
Accepted by the SEC: Wed Feb 19 2020
Period: Tuesday, December 31, 2019
Industry: Hospital And Medical Service Plans